GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk

Background GlycA is a novel spectroscopic marker of systemic inflammation with low intra-individual variability and other attributes favoring its clinical use in patients with chronic inflammatory and autoimmune diseases. GlycA is unique in its composite nature, reflecting both increased glycan comp...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of translational medicine Ročník 15; číslo 1; s. 219 - 5
Hlavní autori:	Connelly, Margery A., Otvos, James D., Shalaurova, Irina, Playford, Martin P., Mehta, Nehal N.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 27.10.2017 BioMed Central Ltd Springer Nature B.V BMC
Predmet:	Acetylglucosamine - blood Biological markers Biomarkers - blood Biomedical and Life Sciences Biomedicine C-Reactive Protein - metabolism Cardiovascular Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - blood Cardiovascular Diseases - mortality GlycA Health aspects Health risk assessment Humans Identification and classification Inflammation Inflammation - blood Medicine/Public Health Metabolic and Lipoprotein Translation Mortality NMR Nuclear magnetic resonance Nuclear magnetic resonance spectroscopy Review Risk Factors Nuclear magnetic resonance spectroscopy GlycA Cardiovascular disease Inflammation
ISSN:	1479-5876, 1479-5876
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!